{"id":"W2947829857","doi":"10.1200/jco.2019.37.15_suppl.4012","title":"Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Nivolumab; Sorafenib; Gastroenterology; Hepatocellular carcinoma; Clinical endpoint; Randomized controlled trial; Adverse effect; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002062566,0.0002066181,0.001409172,0.0001758667,0.00003014371,0.00001179552,0.0002209547,0.0004069723,0.0001868296],"category_scores_gemma":[0.0004429129,0.0001424974,0.0003565376,0.0002459022,0.0001487727,0.0002141681,0.00002886856,0.0008719824,0.00002816057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004180789,"about_ca_system_score_gemma":0.0009850803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002335362,"about_ca_topic_score_gemma":0.0000656693,"domain_scores_codex":[0.995874,0.0004064387,0.002560232,0.0003276462,0.0005490692,0.0002825896],"domain_scores_gemma":[0.9959422,0.0008951198,0.002098861,0.0003597578,0.0005168177,0.0001872944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1798624,0.00277189,0.6433387,0.0000127638,0.0002629441,0.0001386418,0.000256283,0.000008314402,0.0009249151,0.000007223628,0.0003868495,0.1720291],"study_design_scores_gemma":[0.1474484,0.04053158,0.7951231,0.0002045202,0.00006183172,0.00001896476,0.0001114414,0.0002783202,0.0005891951,0.00008373069,0.01540365,0.0001452337],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940405,0.0005133669,0.00001104372,0.002043206,0.001417031,0.0006221249,0.00001451714,0.00001176952,0.00132641],"genre_scores_gemma":[0.9961723,0.001069136,0.0006801333,0.00143441,0.0002513127,0.000004532975,0.00003911979,0.00002955473,0.0003194664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1718839,"threshold_uncertainty_score":0.5810875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04717758825668757,"score_gpt":0.3612129806940574,"score_spread":0.3140353924373698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}